JFNIX Mutual Fund
JFNIX Mutual Fund
JFNIX Mutual Fund
Janus Henderson Global Life Sciences Fund Class I
JFNIX Mutual Fund Overview
JFNIX Mutual Fund (Janus Henderson Global Life Sciences Fund Class I) is managed by Janus Henderson Investors with $717.9M in net assets. JFNIX expense ratio is 0.78%, holding 109 positions across sectors including Health Care, Financials. Inception date: 2009-07-06.
JFNIX performance shows a YTD return of 8.10%. The 1-year return is 40.15% and the 5-year return is 8.43%. JFNIX dividend yield stands at 4.07%, paid annually.
JFNIX top holdings include Eli Lilly & Co. (8.8%), Johnson & Johnson - Common (7.3%), AstraZeneca PLC (4.6%), Abbvie Inc. (4.0%), Unitedhealth Group Incorporated (3.1%). Go to all JFNIX holdings, JFNIX sectors, or JFNIX dividends.
JFNIX can be compared against other funds. Use JFNIX overlap to find shared positions, or JFNIX vs another fund for a side-by-side view. JFNIX alternatives are available via the screener, along with tax-loss harvesting opportunities.